InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Johnson Kenneth Erland. Director active across 2 companies, notably Xeris Pharmaceuticals INC. Cumulatively, 8 reports have been logged. History available since 3 January 2022. The latest transaction was disclosed on 31 January 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Johnson Kenneth Erland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
15,476 股@ US$3.5647.8% 占其流量Common StockSEC:0001867096-25-000023:0
12,401 股@ US$3.6139.4% 占其流量Common StockSEC:0001867096-25-000013:0
7,497 股@ US$2.1112.8% 占其流量Common StockSEC:0001867096-24-000169:0
175,000 股0Common StockSEC:0001867096-24-000016:0
100,000 股0Common StockSEC:0001867096-23-000019:0
75,000 股0Common StockSEC:0001867096-22-000010:0
11,250 股Common StockSEC:0000899243-21-039319:0
11,250 股Common StockSEC:0000899243-21-039246:0
8 条申报中的 8 条
About Johnson Kenneth Erland
JOHNSON KENNETH ERLAND is a declarant linked to Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals INC, with 8 filings in total. In the recent filings available, the reported amounts are related to attributions, between 2021-10-05 and 2025-02-03.
